SCHEDULE 13G/A: FMR LLC Updates Passive Stake in Monte Rosa Therapeutics Inc. to 2.8%
Beneficial Ownership Statement
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a passive beneficial ownership of 2.8% in Monte Rosa Therapeutics Inc. as of May 30, 2025.
Summary
- FMR LLC and Abigail P. Johnson, as reporting persons, have filed an Amendment No. 5 to Schedule 13G regarding their beneficial ownership in MONTE ROSA THERAPEUTICS INC.
- As of May 30, 2025, the aggregate amount beneficially owned by each reporting person is 1,750,731 shares of Common Stock.
- This ownership represents 2.8% of the class of securities.
- FMR LLC holds sole voting power over 1,748,585 shares and sole dispositive power over 1,750,731 shares.
- Abigail P. Johnson holds sole dispositive power over 1,750,731 shares.
- Neither reporting person holds shared voting power nor shared dispositive power.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing (Schedule 13G) reporting passive beneficial ownership, providing factual information without indicating positive or negative operational performance or strategic shifts for the issuer.
Positives
- The continued holding of a stake by a major institutional investor like FMR LLC may signal ongoing confidence in Monte Rosa Therapeutics Inc.
Risks
- The filing explicitly states that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer, indicating a passive investment approach by FMR LLC and Abigail P. Johnson.
Future Outlook
NA
Industry Context
This filing is a routine disclosure by a large asset manager, FMR LLC, regarding its passive investment in a publicly traded company. It reflects standard portfolio management activities rather than specific industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant passive ownership stakes in the company.
Key Dates
| Date | Description |
|---|---|
| 01/03/2023 | Effective date of Power of Attorney for FMR LLC. |
| 01/26/2023 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 01/31/2023 | Reference date for Abigail P. Johnson's Power of Attorney filing (accession number -23-000038). |
| 05/30/2025 | Date of event which requires the filing of this statement. |
| 06/05/2025 | Date of filing of this Schedule 13G Amendment No. 5. |
Keywords
Monte Rosa Therapeutics, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, common stock, institutional investment, passive investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.